BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32234882)

  • 21. Clinicopathological significance of tumor-infiltrating lymphocytes and programmed death-1 expression in cutaneous melanoma: a comparative study on clinical subtypes.
    Lee WJ; Lee YJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Melanoma Res; 2018 Oct; 28(5):423-434. PubMed ID: 29634635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlations.
    Iacono D; Cinausero M; Gerratana L; Angione V; Scott CA; De Maglio G; Pizzolitto S; Di Loreto C; Puglisi F; Fasola G; Minisini AM
    Melanoma Res; 2018 Dec; 28(6):547-554. PubMed ID: 29794562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
    Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis.
    Kümper S; Mardakheh FK; McCarthy A; Yeo M; Stamp GW; Paul A; Worboys J; Sadok A; Jørgensen C; Guichard S; Marshall CJ
    Elife; 2016 Jan; 5():e12994. PubMed ID: 26765561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rho-associated coiled-coil kinase (ROCK) signaling and disease.
    Schofield AV; Bernard O
    Crit Rev Biochem Mol Biol; 2013; 48(4):301-16. PubMed ID: 23601011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.
    de Moll EH; Fu Y; Qian Y; Perkins SH; Wieder S; Gnjatic S; Remark R; Bernardo SG; Moskalenko M; Yao J; Ferringer T; Chang R; Chipuk J; Horst BA; Birge MB; Phelps RG; Saenger YM
    Cancer Immunol Immunother; 2015 Sep; 64(9):1193-203. PubMed ID: 26076664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing signaling of ROCK1 and ROCK2 determines the switching of substrate specificity and the mode of migration of glioblastoma cells.
    Mertsch S; Thanos S
    Mol Neurobiol; 2014 Apr; 49(2):900-15. PubMed ID: 24170433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway.
    Liu JL; Li J; Xu JJ; Xiao F; Cui PL; Qiao ZG; Chen XD; Tao WD; Zhang XL
    Mol Pharmacol; 2019 Apr; 95(4):451-461. PubMed ID: 30674565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
    Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
    Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma.
    Liu H; He Z; von Rütte T; Yousefi S; Hunger RE; Simon HU
    Sci Transl Med; 2013 Sep; 5(202):202ra123. PubMed ID: 24027027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of adhesion complex turnover by ROCK1 and ROCK2.
    Lock FE; Ryan KR; Poulter NS; Parsons M; Hotchin NA
    PLoS One; 2012; 7(2):e31423. PubMed ID: 22348083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.
    Dourado MR; de Oliveira CE; Sawazaki-Calone I; Sundquist E; Coletta RD; Salo T
    J Oral Pathol Med; 2018 Feb; 47(2):121-127. PubMed ID: 29052912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas.
    Lin RL; Wang TJ; Joyce CJ; Mihm MC; Murphy GF; Lian CG; Lin JY
    Melanoma Res; 2016 Oct; 26(5):524-7. PubMed ID: 26974966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma.
    Kaczorowski M; Biecek P; Donizy P; Pieniazek M; Matkowski R; Halon A
    Transl Res; 2019 Feb; 204():72-81. PubMed ID: 30342000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Rho kinase isoforms in lung endothelial cells during inflammation.
    Mong PY; Wang Q
    J Immunol; 2009 Feb; 182(4):2385-94. PubMed ID: 19201893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
    Huang GX; Wang Y; Su J; Zhou P; Li B; Yin LJ; Lu J
    Cancer Lett; 2017 Dec; 410():1-11. PubMed ID: 28923399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.